You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Topoisomerase Inhibitors

Showing 1 - 25 of 4,222
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Solid Tumor, Metastatic Neuroendocrine Carcinoma Trial in United

Recruiting
  • Metastatic Lung Small Cell Carcinoma
  • +16 more
  • Phoenix, Arizona
  • +10 more
Mar 25, 2022

HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)

Recruiting
  • HRD Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Small Cell Lung Cancer, Extra-Pulmonary Small Cell Carcinomas Trial run by the NCI (PLX038, Rucaparib)

Active, not recruiting
  • Small Cell Lung Cancer
  • Extra-Pulmonary Small Cell Carcinomas
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Tumors, Lymphoma Trial run by the National Cancer Institute (NCI) (LMP400, LMP776)

Completed
  • Neoplasms
  • Lymphoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022

SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)

Recruiting
  • SCLC
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)

Recruiting
  • Neuroblastoma
  • Naxitamab monotherapy
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 31, 2023

Cancer Trial (Empagliflozin 10 MG)

Not yet recruiting
  • Cancer
  • Empagliflozin 10 MG
  • (no location specified)
Oct 22, 2023

Urothelial Carcinoma, Urothelial Cancer, Lung Tumors Trial run by the NCI (EP0057, olaparib)

Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Endometrial Serous Adenocarcinoma, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States

Recruiting
  • Endometrial Serous Adenocarcinoma
  • +2 more
  • Biopsy
  • +3 more
  • Phoenix, Arizona
  • +3 more
Feb 2, 2023

Gastrointestinal Stromal Tumors Trial in Seoul (Rivoceranib Mesylate, Paclitaxel)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Rivoceranib Mesylate, Paclitaxel
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Jun 7, 2023

Colorectal Cancer, Metastatic Cancer Trial in United States (dexamethasone, floxuridine, fluorouracil)

Active, not recruiting
  • Colorectal Cancer
  • Metastatic Cancer
  • Basking Ridge, New Jersey
  • +4 more
Feb 4, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Beijing, Beijing, China
    Lingying Wu
Aug 22, 2023

Gastrointestinal Cancer Trial in Philadelphia (Pharmacogenetic test)

Recruiting
  • Gastrointestinal Cancer
  • Pharmacogenetic test
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 18, 2022

Breast Cancer Trial in China (TQB2102 for injection)

Not yet recruiting
  • Breast Cancer
  • TQB2102 for injection
  • Hefei, Anhui, China
  • +20 more
Nov 1, 2023

Advanced Cancer Trial in Guangzhou (TQB2102 injection)

Not yet recruiting
  • Advanced Cancer
  • TQB2102 injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 23, 2023

Adenocarcinoma, Gastric, Tumor, Breast Trial in Taipei (DS-8201a)

Completed
Has Results
  • Adenocarcinoma, Gastric
  • Neoplasm, Breast
  • Taipei, Taiwan
  • +1 more
Nov 2, 2022

Pineoblastoma Trial in Regensburg (Temozolomide, Irinotecan, Dasatinib)

Completed
  • Pineoblastoma
  • Regensburg, Germany
    University Hospital of Regensburg
Jul 29, 2021

CLL/SLL Trial (lisaftoclax +BTK inhibitor, BTK inhibitor)

Not yet recruiting
  • CLL/SLL
  • lisaftoclax +BTK inhibitor
  • BTK inhibitor
  • (no location specified)
Oct 26, 2023

Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

Recruiting
  • Acute Myeloid Leukemia
  • Venclexta 100 MG Oral Tablet
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023

Myelofibrosis Trial in Jinan (TQ05105 tablets, Itraconazole capsule, Rifampicin Capsule)

Not yet recruiting
  • Myelofibrosis
  • TQ05105 tablets
  • +2 more
  • Jinan, Shandong, China
    Shandong Provincial Hospital
Aug 30, 2023

Advanced Breast Cancer Trial in Beijing (The combination of Dalpiciclib with physician-selected endocrine therapy, Chemotherapy

Recruiting
  • Advanced Breast Cancer
  • The combination of Dalpiciclib with physician-selected endocrine therapy
  • Chemotherapy selected by the physician
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 22, 2023

Gastrointestinal Stromal Tumors Trial in Seoul (Paclitaxel)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 30, 2022

Musculoskeletal Health in Breast Cancer During Aromatase

Recruiting
  • Musculoskeletal Health
  • No intervention
  • Shanghai, Shanghai, China
    School of Nursing, Fudan University
Jun 16, 2023

SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac

Recruiting
  • Coronary Artery Disease
  • Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
  • Shah Alam, Selangor, Malaysia
    Institute for Clinical Research, National Institutes of Health,
Nov 9, 2023

Bile Acids in Acute Insulin Resistance

Recruiting
  • PI3K Gene Mutation
  • +4 more
  • Drug-induced acute insulin resistance due to PI3K inhibitor, AKT inhibitor, or mTOR inhibitor
  • New York, New York
    Columbia University Medical Center
Oct 6, 2022